257 related articles for article (PubMed ID: 20001576)
1. Meta-analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases.
Szajewska H; Horvath A
Curr Med Res Opin; 2010 Feb; 26(2):423-37. PubMed ID: 20001576
[TBL] [Abstract][Full Text] [Related]
2. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
Halken S
Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
[TBL] [Abstract][Full Text] [Related]
3. Partially hydrolysed 100% whey-based infant formula and the prevention of atopic dermatitis: comparative pharmacoeconomic analyses.
Spieldenner J; Belli D; Dupont C; Haschke F; Iskedjian M; Nevot Falcó S; Szajewska H; von Berg A
Ann Nutr Metab; 2011; 59 Suppl 1():44-52. PubMed ID: 22189255
[TBL] [Abstract][Full Text] [Related]
4. Extensively and partially hydrolysed preterm formulas in the prevention of allergic diseases in preterm infants: a randomized, double-blind trial.
Szajewska H; Mrukowicz JZ; Stoińska B; Prochowska A
Acta Paediatr; 2004 Sep; 93(9):1159-65. PubMed ID: 15384877
[TBL] [Abstract][Full Text] [Related]
5. Modified proteins in allergy prevention.
von Berg A
Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():239-47; discussion 247-57. PubMed ID: 19710526
[TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of a 100% whey-based partially hydrolyzed infant formula in the prevention of atopic dermatitis among Danish children.
Iskedjian M; Haschke F; Farah B; van Odijk J; Berbari J; Spieldenner J
J Med Econ; 2012; 15(2):394-408. PubMed ID: 22171936
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of partially-hydrolyzed formula for prevention of atopic dermatitis in Australia.
Su J; Prescott S; Sinn J; Tang M; Smith P; Heine RG; Spieldenner J; Iskedjian M
J Med Econ; 2012; 15(6):1064-77. PubMed ID: 22630113
[TBL] [Abstract][Full Text] [Related]
8. Partially hydrolyzed 100% whey protein infant formula and reduced risk of atopic dermatitis: a meta-analysis.
Alexander DD; Cabana MD
J Pediatr Gastroenterol Nutr; 2010 Apr; 50(4):422-30. PubMed ID: 20216095
[TBL] [Abstract][Full Text] [Related]
9. Economic evaluation of a 100% whey-based partially hydrolyzed infant formula in the prevention of atopic dermatitis among Swiss children.
Iskedjian M; Belli D; Farah B; Navarro V; Detzel P
J Med Econ; 2012; 15(2):378-93. PubMed ID: 22171935
[TBL] [Abstract][Full Text] [Related]
10. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three-year results of the German Infant Nutritional Intervention Study.
von Berg A; Koletzko S; Filipiak-Pittroff B; Laubereau B; Grübl A; Wichmann HE; Bauer CP; Reinhardt D; Berdel D;
J Allergy Clin Immunol; 2007 Mar; 119(3):718-25. PubMed ID: 17240440
[TBL] [Abstract][Full Text] [Related]
11. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long-term results from the German Infant Nutritional Intervention Study (GINI).
von Berg A; Filipiak-Pittroff B; Krämer U; Link E; Bollrath C; Brockow I; Koletzko S; Grübl A; Heinrich J; Wichmann HE; Bauer CP; Reinhardt D; Berdel D;
J Allergy Clin Immunol; 2008 Jun; 121(6):1442-7. PubMed ID: 18539195
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of a partially hydrolysed 100%-whey infant formula vs. extensively hydrolysed infant formulas in the prevention of atopic dermatitis.
Iskedjian M; Szajewska H; Spieldenner J; Farah B; Berbari J
Curr Med Res Opin; 2010 Nov; 26(11):2599-606. PubMed ID: 20925453
[TBL] [Abstract][Full Text] [Related]
13. Hypersensitivity to hydrolyzed cow's milk protein formula in infants and young children with atopic eczema/dermatitis syndrome with cow's milk protein allergy.
Kaczmarski M; Wasilewska J; Lasota M
Rocz Akad Med Bialymst; 2005; 50():274-8. PubMed ID: 16358982
[TBL] [Abstract][Full Text] [Related]
14. Infant Formulas With Partially or Extensively Hydrolyzed Milk Proteins for the Prevention of Allergic Diseases: A Systematic Review and Meta-Analysis of Clinical Trials.
Li X; He T; Duan S; Liang J; Feng G; Li F; Shen Z; Ye W; Liu B; Jiang B; Chen Y; Liu N; Szeto IM; Cai L
Adv Nutr; 2024 May; 15(5):100217. PubMed ID: 38579971
[TBL] [Abstract][Full Text] [Related]
15. Sustainable clinical research, health economic aspects and medical marketing: drivers of product innovation.
Haschke F; Klassen-Wigger P
Nestle Nutr Workshop Ser Pediatr Program; 2010; 66():125-41. PubMed ID: 20664221
[TBL] [Abstract][Full Text] [Related]
16. Allergies in high-risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10-year results from the German Infant Nutritional Intervention (GINI) study.
von Berg A; Filipiak-Pittroff B; Krämer U; Hoffmann B; Link E; Beckmann C; Hoffmann U; Reinhardt D; Grübl A; Heinrich J; Wichmann HE; Bauer CP; Koletzko S; Berdel D;
J Allergy Clin Immunol; 2013 Jun; 131(6):1565-73. PubMed ID: 23506844
[TBL] [Abstract][Full Text] [Related]
17. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study.
Halken S; Hansen KS; Jacobsen HP; Estmann A; Faelling AE; Hansen LG; Kier SR; Lassen K; Lintrup M; Mortensen S; Ibsen KK; Osterballe O; Høst A
Pediatr Allergy Immunol; 2000 Aug; 11(3):149-61. PubMed ID: 10981524
[TBL] [Abstract][Full Text] [Related]
18. FDA's health claim review: whey-protein partially hydrolyzed infant formula and atopic dermatitis.
Chung CS; Yamini S; Trumbo PR
Pediatrics; 2012 Aug; 130(2):e408-14. PubMed ID: 22778306
[TBL] [Abstract][Full Text] [Related]
19. Hypoallergenic formulas--when, to whom and how long: after more than 15 years we know the right indication!
Høst A; Halken S
Allergy; 2004 Aug; 59 Suppl 78():45-52. PubMed ID: 15245358
[TBL] [Abstract][Full Text] [Related]
20. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high-risk children: a randomized controlled trial.
Lowe AJ; Hosking CS; Bennett CM; Allen KJ; Axelrad C; Carlin JB; Abramson MJ; Dharmage SC; Hill DJ
J Allergy Clin Immunol; 2011 Aug; 128(2):360-365.e4. PubMed ID: 21696814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
